Gordon Ko

ORCID: 0000-0002-2295-592X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Myofascial pain diagnosis and treatment
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Botulinum Toxin and Related Neurological Disorders
  • Musculoskeletal pain and rehabilitation
  • Pain Management and Placebo Effect
  • Cannabis and Cannabinoid Research
  • Shoulder Injury and Treatment
  • Complementary and Alternative Medicine Studies
  • Pain Management and Treatment
  • Pain Mechanisms and Treatments
  • Spine and Intervertebral Disc Pathology
  • Religion, Spirituality, and Psychology
  • Migraine and Headache Studies
  • Poisoning and overdose treatments
  • Systemic Sclerosis and Related Diseases
  • Parkinson's Disease and Spinal Disorders
  • Intracranial Aneurysms: Treatment and Complications
  • Clinical Reasoning and Diagnostic Skills
  • Clinical practice guidelines implementation
  • Muscle metabolism and nutrition
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Pelvic and Acetabular Injuries
  • Trigeminal Neuralgia and Treatments
  • Toxin Mechanisms and Immunotoxins
  • Neuroscience of respiration and sleep

Sunnybrook Health Science Centre
2000-2020

Health Sciences Centre
2002-2020

University of Toronto
2000-2020

Applied Research (United States)
2016

Université de Montréal
2013

St. John's Rehab Hospital
2007

Sunnybrook Hospital
2005

Women's College Hospital
2005

BACKGROUND: Recent neurophysiological evidence attests to the validity of fibromyalgia (FM), a chronic pain condition that affects >2% population. OBJECTIVES: To present evidence-based guidelines for diagnosis, management and patient trajectory individuals with FM. METHODS: A needs assessment following consultation diverse health care professionals identified questions pertinent various aspects literature search available address these questions; was graded according standards Oxford...

10.1155/2013/918216 article EN cc-by Pain Research and Management 2013-01-01

To evaluate the short-term and long-term effects of plant-based medical cannabis in a chronic pain population over course one year.A longitudinal, prospective, 12-month observational study.Patients were recruited treated at clinic specializing care from October 2015 to March 2019.A total 751 patients initiating treatment.Study participants completed Brief Pain Inventory 12-item Short Form Survey (SF-12), as well surveys on opioid medication use adverse events, baseline once month for 12...

10.1093/pm/pnaa163 article EN Pain Medicine 2020-04-25

The aim of this case series study was to investigate and report on patients with neuropathic pain who responded treatment omega-3 fatty acids.Methods: Five different underlying diagnoses including cervical radiculopathy, thoracic outlet syndrome, fibromyalgia, carpal tunnel burn injury were treated high oral doses omega 3 fish oil (varying from 2400-7200 mg/day EPA-DHA). Outcome measures obtained pretreatment posttreatment. These included validated surveys (short-form McGill Pain...

10.1097/ajp.0b013e3181bb8533 article EN Clinical Journal of Pain 2010-01-19

BACKGROUND: Two-thirds of adults worldwide will experience low back pain at some point in their life. In the following case series, we present four patients with sacroiliac (SI) joint instability and severe chronic pain, which was refractory to other treatment modalities. OBJECTIVE: We inv estigated efficacy platelet-rich plasma (PRP) injections, a novel orthobiologic therapy, for reducing SI improving quality life, maintaining clinical effect. METHODS: Short-form McGill Pain Questionnaire...

10.3233/bmr-160734 article EN Journal of Back and Musculoskeletal Rehabilitation 2016-07-05

Objective. To summarize the development of evidence-based guidelines for clinical care persons with fibromyalgia (FM), taking into account advances in understanding pathogenesis FM, new diagnostic criteria, and treatment options. Methods. Recommendations diagnosis, treatment, patient followup were drafted according to classification system Oxford Centre Evidence-Based Medicine, following review endorsed by Canadian Rheumatology Association Pain Society. Results. FM is a polysymptomatic...

10.3899/jrheum.130127 article EN The Journal of Rheumatology 2013-07-01

10.1016/s0003-9993(00)90051-0 article EN Archives of Physical Medicine and Rehabilitation 2000-05-01

Objective: To review the literature on topical pain management in fibromyalgia [FMS] and to report effective treatment with O24 essential oils.Methods: Following a of MEDLINE EMBASE for published randomized controlled trials therapies FMS treatment, double-blinded placebo trial was carried out outpatient clinics 153 subjects meeting American College Rheumatology criteria using oils period one month. Main outcome measures were visual analog scale ratings, diary, Fibromyalgia Impact...

10.1300/j094v15n01_03 article EN Journal of Musculoskeletal Pain 2007-01-01

There is a paucity of long-term treatment benefit and safety data botulinum toxin A (BTX-A) for cervical dystonia (CD) myofascial neck pain syndrome (MPS). Additionally, the prevalence adjunct modality uses during this period unknown despite evolving practices.To assess compare benefit, safety, prevalences BTX-A injections between CD MPS patients.Retrospective cohort study.Private practice tertiary care clinics in Toronto.Convenience sample 37 (52.9%) 33 (47.1%) patients treated mean±SD...

10.2147/jpr.s254032 article EN cc-by-nc Journal of Pain Research 2020-06-01

Background: These case reports document effective treatment using botulinum toxin type-A [BTX-A] in fibromyalgia syndrome [FMS] patients. Outcome measures [including pain scales, Fibromyalgia Impact Questionnaire, algometry] were recorded on 25 FMS patients undergoing repeated BTX-A injections [one to five years duration].Findings: Pain and function improved these Muscles injected with good response included the frontalis, corrugators [for headache], levator scapulae, pectoralis minor [neck/...

10.1300/j094v15n04_07 article EN Journal of Musculoskeletal Pain 2007-01-01

ABSTRACT: The current standard of care medical model is a disease-based approach, focused on achieving specific diagnosis and applying monotherapy to the labeled condition. Chronic fatigue syndrome (CFS), not dissimilar other complex syndromes may require different viewpoint improve patient outcomes.  This that would be adequately suited for conditions must intervene at multiple levels address core clinical imbalances.  In these syndromes, determination appropriate treatment options...

10.18103/mra.v5i12.1573 article EN 2017-12-15

10.1053/mr.2000.3862 article EN Archives of Physical Medicine and Rehabilitation 2000-05-01

Background. To present a case series of nine multiple sclerosis (MS) patients with neuropathic pain improved the oral cannabinoid, Nabilone. Methods. MS referred from family physicians and neurologists were pre-screened DN4 questionnaire for EDSS. Exclusion criteria included severe psychiatric disease addiction risk. Patients assessed Numerical rating scale pain, Short-form McGill Pain Questionnaire, Disability Index, Neuropathic Scale, Diagram. Physical examination also jamar grip...

10.1016/j.ejpain.2007.03.329 article EN European Journal of Pain 2007-05-10
Coming Soon ...